Lit Rev and Comment 7-12

by , | Jul 1, 2012

Post Categories: Nutrition and Lifestyle

Literature Review and Commentary

by Alan R. Gaby, MD

Increasing Dietary Protein Improves Polycystic Ovary Syndrome

Fifty-seven women (mean age, 28 years; mean body weight, 85 kg) with polycystic ovary syndrome were randomly assigned to a high-protein diet or a standard-protein diet for six months. The high-protein diet provided more than 40% of energy from protein and 30% from fat, while the standard-protein diet provided less than 15% of energy from protein and 30% from fat. Twenty-seven women completed the study. After six months, mean weight loss was significantly greater by 4.4 kg (p = 0.002), and mean loss of body fat was significantly greater by 4.3 kg (p = 0.002) on the high-protein diet than on the standard-protein diet. Mean fasting plasma glucose decreased significantly more on the high-protein diet than on the standard-protein diet; this difference persisted after adjustment for weight changes (p = 0.03). There were no differences between groups in levels of testosterone or lipids.

Comment

: This study found that, in women with polycystic ovary syndrome, consumption of a high-protein, low-carbohydrate diet promoted weight loss and improved glucose metabolism by an effect that may be independent of weight loss. Various nutritional supplements have also been reported to improve glucose metabolism, reduce testosterone levels, or restore ovulation in women with polycystic ovary syndrome; these include D-chiro-inositol, chromium, N-acetylcysteine, and vitamin D.

Gaby AR. Nutritional Medicine. 2011; chapter 226. www.doctorgaby.com.

Sorensen LB et al. Effects of increased dietary protein-to-carbohydrate ratios in women with polycystic ovary syndrome. Am J Clin Nutr. 2012;95:39–48.

Omega-3 Fatty Acids Also Beneficial for Polycystic Ovary Syndrome

In a cross-sectional study of 104 women (mean age, 28.3 years) with polycystic ovary syndrome (PCOS), greater plasma omega-6 polyunsaturated fatty acid (PUFA) concentrations and greater omega-6:omega-3 PUFA ratios were associated with higher circulating androgen levels. Twenty-two women with PCOS were randomly assigned to receive, in double-blind fashion, 4 g per day of an omega-3 fatty acid supplement or placebo (olive oil) for 6 weeks. After a 6-week washout period, each woman received the alternate treatment for an additional 6 weeks. The omega-3 fatty acid supplement provided 1.9 g per day of EPA + DHA in a ratio of 1.49:1 (EPA:DHA). Compared with placebo, active treatment reduced the mean serum concentration of bioavailable testosterone by 25% (p < 0.05). In bovine theca cells, arachidonic acid modulated androstenedione secretion, which suggests an indirect effect of omega-3 fatty acids through the displacement of, or increased competition with, omega-6 fatty acids.

Comment

: Omega-3 fatty acids can now be added to the list (see above) of dietary modifications and nutritional supplements that may be of value for women with PCOS. The dosage of omega-3 fatty acids used in this study would be equivalent to about 6 g per day of fish oil.

Phelan N et al. Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial. Am J Clin Nutr. 2011;93:652–662.

Food Allergy: a Major Factor in Eosinophilic Esophagitis

Of 17 children with eosinophilic esophagitis, 15 were found to be allergic to one or more foods, as determined by skin prick tests, patch tests, and specific IgE tests. The most frequently implicated foods were cow’s milk (n = 8), egg (n = 6), wheat (n = 4), fish (n = 4), and nuts (n = 3). Eight or 9 patients (exact number unclear) were cured by avoidance of allergenic foods. One patient did not respond to the avoidance of foods determined to be allergenic by testing, but that patient responded to an elemental (antigen-free) diet. In 2 other patients, no food allergies were identified by allergy testing, but the condition was cured by an elemental diet, following which the offending foods were identified by individual food challenges.

Comment

: Eosinophilic esophagitis is a chronic inflammatory disorder of the esophagus characterized by eosinophilic infiltration of the esophageal epithelium. Esophageal strictures are frequently found on endoscopic examination. Eosinophilic esophagitis occurs primarily in children but is becoming increasingly common in adults as well, and the overall incidence has been rising. Symptoms may include heartburn, dysphagia, vomiting, failure to thrive, abdominal pain, and impaction of food. Although the clinical presentation often resembles gastroesophageal reflux disease (GERD), eosinophilic esophagitis is a distinct clinical entity which, unlike GERD, does not respond to acid suppression. The results of this study confirm previous studies demonstrating that that eosinophilic esophagitis is caused mainly by food allergy.

Rizo Pascual JM et al. Allergy assessment in children with eosinophilic esophagitis. J Investig Allergol Clin Immunol. 2011;21:59–65.

Treating Idiopathic Intracranial Hypertension with Diet

Twenty obese women (mean age, 34 years; mean body mass index [BMI], 38.2 kg/m2) with idiopathic intracranial hypertension for more than 3 months were prescribed a low-energy diet (425 kcal per day) for 3 months. After 3 months, mean BMI fell to 32.6 kg/m2, and significant improvements were seen in intracranial pressure, headache severity, and papilledema. In addition, compared with baseline, significantly fewer women reported symptoms of tinnitus, diplopia, and obscurations (transient loss of vision). Reevaluation at 3 months after the end of the study revealed that weight loss and clinical improvements were maintained.

Comment

: Idiopathic intracranial hypertension (also known as benign intracranial hypertension or pseudotumor cerebri) is characterized by increased intracranial pressure and papilledema. It is seen most often in young, obese women (the incidence among obese women is 20 per 100,000). Manifestations may include severe daily headaches and loss of vision, which is permanent in up to 25% of cases. The results of the present study suggest that caloric restriction can improve the signs and symptoms of idiopathic intracranial hypertension in obese women.

Sinclair AJ et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010;341:c2701.

Melatonin for Tinnitus

Sixty-one patients (mean age, 57.8 years) with chronic tinnitus not due to known structural lesions were randomly assigned to receive, in double-blind fashion, 3 mg of melatonin or placebo each night for 30 days. After a 1-month washout period, each patient received the alternate treatment for an additional 30 days. The mean duration of tinnitus prior to the study was 11.3 years, and 85% of the cases were bilateral. The median scores for scales that measured tinnitus intensity and severity improved to a significantly greater extent during melatonin treatment than during placebo treatment. Factors associated with a greater response to melatonin included male gender, bilateral tinnitus, history of noise exposure, no prior tinnitus treatment, absence of depression and/or anxiety at baseline, and more severe tinnitus at baseline. Sleep quality (as determined by the Pittsburgh Sleep Quality Index) improved more with melatonin than with placebo, but the difference was not statistically significant.

Comment

: This study confirms the results of two other double-blind studies, in which melatonin either improved tinnitus or decreased sleeping difficulties related to tinnitus. The mechanism of action of melatonin is not known. Considering that melatonin is relatively safe, and that tinnitus is often difficult to treat, this hormone should be considered for first-line treatment of tinnitus, particularly in patients who have characteristics that predict a positive response to melatonin.

Hurtuk A et al. Melatonin: can it stop the ringing? Ann Otol Rhinol Laryngol. 2011;120:433–440.

Omega-3 Fatty Acids for Depression

Four hundred thirty-two Canadian adults (mean age, 46 years) with a major depressive episode lasting at least 4 weeks were randomly assigned to receive, in double-blind fashion, 1050 mg per day of eicosapentaenoic acid (EPA) and 150 mg per day of docosahexaenoic acid (DHA) or placebo (sunflower oil) for 8 weeks. Forty percent of the patients were taking antidepressants at baseline. The mean improvement on the self-report Inventory of Depressive Symptomatology was nonsignificantly greater in the active-treatment group than in the placebo group (29.3% vs. 25.4%; p = 0.088). The mean improvement on the Montgomery-Asberg Depression Rating Scale was also nonsignificantly greater in the active-treatment group than in the placebo group (28.7% vs. 27%; p = 0.053). In planned subgroup analysis, for patients without comorbid anxiety disorders (n = 204), active treatment was significantly superior to placebo on both scales (p < 0.01 for each). No difference between treatments was seen in patients with comorbid anxiety disorders.

Comment

: Depressed patients have been found to have low levels of circulating omega-3 fatty acids, or low levels relative to the concentration of omega-6 fatty acids. Some previous studies have found that supplementation with fish oil or with EPA and DHA produced substantial benefit in patients with depression. However, omega-3 fatty acids were ineffective in other studies. The discrepant findings in different studies might be explainable in part by differences in patient populations. The results of the present study suggest that omega-3 fatty acids are beneficial for depressed patients only if they do not also suffer from an anxiety disorder.

Lesperance F et al. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. J Clin Psychiatry. 2011;72:1054–1062.

Fish Oil Does Not Increase Risk of Bleeding During Surgery

Ninety-five patients who underwent posterior lumbar decompression surgery by a single surgeon were studied retrospectively. Sixteen patients took omega-3 fatty acid supplements within 14 days of surgery, stopping an average of 2.3 days before surgery (cases), and the other patients did not take such supplements within 14 days of surgery (controls). There was no significant difference between cases and controls in demographic parameters, use of other anticoagulants, or surgical time. Mean estimated blood loss was nonsignificantly higher in cases than in controls (154 vs. 138 ml; p = 0.53). There were two complications related to bleeding in the control group and none in the omega-3 fatty acid group. The authors cited five other studies in which the use of omega-3 fatty acids was not associated with increased risk of bleeding complications, blood loss, or transfusion requirements in patients undergoing abdominal surgery or coronary bypass surgery.

Comment

: Because fish oil inhibits platelet function, there is concern that it could increase the amount of bleeding during surgery. Most surgeons therefore recommend that fish oil not be taken before surgery. However, the results of this new study and other studies suggest that it is safe to take omega-3 fatty acid supplements, at least up to two days prior to undergoing surgery.

Kepler CK et al. Omega-3 and fish oil supplements do not cause increased bleeding during spinal decompression surgery. J Spinal Disord Tech. Epub 2011;Mar 16.

Coenzyme Q10 for Duchenne Muscular Dystrophy

Thirteen patients (aged 5-10 years) with Duchenne muscular dystrophy who were on stable prednisone therapy for more than 6 months were treated with coenzyme Q10 (CoQ10). For the first 3 patients, the starting dose was 90 mg per day, which was increased by 30 mg per day at intervals until the serum CoQ10 level reached 2.5 mcg/ml. After the first 3 patients were unable to rapidly achieve the desired serum level, the protocol was changed to an initial dose of 400 mg per day with 100 mg per day increases. After the desired serum level was reached, the patients continued the treatment for 6 months, with dosage adjustments made as needed. Twelve patients completed the trial, of which 9 showed an improvement in the total quantitative muscle testing score. Overall, CoQ10 treatment resulted in an 8.5% increase in mean muscle strength (p = 0.03).

Comment

: Glucocorticoids such as prednisone slow disease progression in patients with Duchenne muscular dystrophy, and glucocorticoid therapy is considered the standard of care. The results of the present study suggest that the addition of CoQ10 to prednisone therapy can increase in muscle strength in patients with this condition.

Spurney CF et al. CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy. Muscle Nerve. 2011;44:174–178.

Authors

  • Alan R. Gaby, MD

    Dr. Gaby received his undergraduate degree from Yale University, his M.S. in biochemistry from Emory University, and his M.D. from the University of Maryland. He is past-president of the American Holistic Medical Association and gave expert testimony to the White House Commission on Complementary and Alternative Medicine on the cost-effectiveness of nutritional supplements. He is the author of numerous books and scientific papers in the field of nutritional medicine. Dr. Gaby was professor of nutrition at Bastyr University for 9 years, and contributed to the nutrition curriculum for the University of Arizona's fellowship program in Integrative Medicine. He is the author of the textbook, Nutritional Medicine, (www.doctorgaby.com), which is being used in 37 countries and by more than 30 graduate and undergraduate nutrition programs. www.doctorgaby.com

    View all posts
  • Erma J Brown, PhN

Already Subscribed?

Search

Formatting updates are ongoing for older articles.

Author

Featured Articles

Where are your Clinical Trials?

It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized. 

A Renewed Focus on Self-Help for Healing

As the producer of The Moss Report, the year leading up to the Covid-19 pandemic was filled with anticipation and excitement. We had invested years of hard work and significant resources into two major projects: our feature film, Immunotherapy: The Battle Within, and...

Issue Archives

Event Calendar

  • 2026 Lifestyle Medicine Conference

    Hybrid Event

    Join us in Orlando, or Online! This event is your gateway to discovering groundbreaking insights from renowned experts at the forefront of healthcare innovation. Total credit opportunities (CME/CE accreditation) for LM2026 are expected to be comparable to prior years across multiple disciplines. Full conference participation will meet—and may exceed—the educational requirements for lifestyle medicine certification.  The annual Lifestyle Medicine Conference unites a dynamic community — online and onsite — committed to reshaping healthcare. Explore how to tackle the root causes of chronic disease and elevate health within every care setting. See why lifestyle medicine can renew your purpose and passion. This year’s agenda explores what it takes to bring lifestyle medicine to life at scale. Learn from clinicians, researchers, health system leaders, educators, and innovators tackling today’s biggest healthcare challenges through evidence-based approaches that improve outcomes, reduce disease burden, and help people thrive.

  • 2026 Annual CoAND Conference & Retreat

    Connect with community to learn & play! After the huge success of having both a retreat and academic style conference last year, we are doing it again, only this time in Manitou Springs! Please join us as we learn from top professionals in our community, engage in hands on learning with our peers, and experience the incredible power of Naturopathic Medicine.  Expert Lectures Classes & Workshops Experiences We have an incredible line up of speakers and presenters for you this year! 

    $399 – $595
  • 2026 Association of Natural Health Conference

    Douglasville Conference Center Douglasville, GA, United States

    "From Practitioner to Leader: Clinical Excellence, Business Mastery & Sustainable Practice" Discover how clinical excellence, business mastery, and sustainable systems can help practitioners grow into confident leaders and build practices designed for long-term impact. Why Attend? Three days of learning, connection, and growth designed for every stage of your practice journey. Learn from Leading Voices Gain insights from top experts in natural health, holistic wellness, and functional medicine. Hands-On Learning Participate in in-depth workshops, real-world case studies, and interactive sessions you can apply immediately. Meaningful Networking Connect with like-minded professionals, students, and exhibitors who share your passion for natural health. Practical Tools & Approaches Explore new strategies and tools to elevate both your practice and your own health journey. Who Should Attend? This conference is built for a wide community of natural health professionals, educators, and advocates - wherever you are in your journey. Licensed & Clinical Practitioners Doctors, chiropractors, acupuncturists, naturopaths, and functional or integrative medicine practitioners looking to sharpen clinical skills and grow into stronger practice leaders. Allied Health Professionals Bio-feedback technicians and other allied practitioners seeking hands-on training and the latest tools in natural and holistic care. Educators & Students Natural health educators and students entering the […]

Related Posts

From Mutation to Metabolism: A Broader View of Cancer Development

By Erik Peper, PhD, BCB, and Richard Harvey, PhD – SMT framework has guided the “War on Cancer” and has led to remarkable advances in targeted therapies, chemotherapy, immunotherapy, and radiation treatments. These strategies have saved countless lives, yet they primarily focus on eliminating malignant cells rather than understanding why normal cells become malignant in the first place.

Read More

The Pharmacy of the Sacred Forest: Medicinal Plants and Ancestral Wisdom of the Jola Healers (Gambia)

By Dr. Josep Lluís Berdonces – “Out of sight, out of mind,” goes a traditional proverb that Malang often repeats. The destruction of sacred forests, the loss of local languages, the disappearance of wise elders without passing on their knowledge: all of this represents a cultural and therapeutic catastrophe of incalculable dimensions.

Read More

0 Comments

Submit a Comment